From: Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
GT 1
GT 2
GT 3
GT 4
SOF + PEG + RBV
12 weeks
43 % (51)
0
12 % (14)
3 % (4)
24 weeks
10 % (12)
SOF + RBV
11 % (13)
8 % (10)
1 % (1)